Advertisement

Topics

CENTOGENE Company Profile

02:31 EDT 18th August 2018 | BioPortfolio

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical companies developing life-changing orphan drugs.


News Articles [24 Associated News Articles listed on BioPortfolio]

CENTOGENE to Open First U.S. Laboratory in Cambridge, MA Focused on Rare Genetic Diseases ...

Centogene:Ruxandra Lenz, +49 30 213 000 323Director CommunicationsRuxandra.Lenz@centogene.comorMedia Contact:MacDougall Biomedical CommunicationsLauren Arnold, +1 781-235-3060larn...

Centogene and Aldeyra Therapeutics Partner to Advance Novel Therapeutics for Patients with Sjögren-Larsson Syndrome

ROSTOCK, Germany–(BUSINESS WIRE)–CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced that it has ente...

Centogene, Aldeyra to advance therapeutics for SLS patients

Centogene has signed an agreement with Aldeyra Therapeutics for the advancement of novel therapeutics for patients with Sjögren-Larsson Syndrome (SLS).

CENTOGENE to Present at the Jefferies 2018 Global Healthcare Conference

CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical partners to identify and accelerate treatments fo...

CENTOGENE to Present at the 2018 BIO International Convention

CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical partners to identify and accelerate treatments fo...

CENTOGENE to Present at the Bio€quity Europe 2018 Conference

CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and enable patients, clinicians and pharmaceutica...

Centogene Publishes Study Identifying the Best Biomarker for Monitoring Response to Therapy for Patients with Gaucher Disease

ROSTOCK, Germany–(BUSINESS WIRE)–CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, announced the publication of a s...

Centogene Partners with the Universities of Greifswald and Rostock to Develop Fast-Tracked Diagnostic Workflow for Personalized Therapies for Colon and Pancreatic Tumors

ROSTOCK, Germany–(BUSINESS WIRE)–CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical partners to identify and acceler...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide d...

More Information about "CENTOGENE" on BioPortfolio

We have published hundreds of CENTOGENE news stories on BioPortfolio along with dozens of CENTOGENE Clinical Trials and PubMed Articles about CENTOGENE for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CENTOGENE Companies in our database. You can also find out about relevant CENTOGENE Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record